{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:49:20Z","timestamp":1787021360157,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1245\/s10434-021-10021-1","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T15:02:31Z","timestamp":1621350151000},"page":"7506-7517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)"],"prefix":"10.1245","volume":"28","author":[{"given":"Irvin M.","family":"Modlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Filosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Frilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Malczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Toumpanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faidon-Marios","family":"Laskaratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Partelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Roffinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"von Arx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata Kos","family":"Kudla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bodei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignat A.","family":"Drozdov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"10021_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3322\/caac.21493","volume":"68","author":"M Cives","year":"2018","unstructured":"Cives M, Strosberg JR. Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin. 2018;68:471\u201387. https:\/\/doi.org\/10.3322\/caac.21493.","journal-title":"CA Cancer J Clin."},{"key":"10021_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000503721","volume":"110","author":"AK Clift","year":"2020","unstructured":"Clift AK, Kidd M, Bodei L, et al. Neuroendocrine neoplasms of the small bowel and pancreas. Neuroendocrinology. 2020;110:444\u201376. https:\/\/doi.org\/10.1159\/000503721.","journal-title":"Neuroendocrinology."},{"key":"10021_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589.","journal-title":"JAMA Oncol."},{"key":"10021_CR4","doi-asserted-by":"publisher","first-page":"16863","DOI":"10.11038\/s41598-16018-35340-16864","volume":"8","author":"C Shen","year":"2018","unstructured":"Shen C, Dasari A, Xu Y, et al. Pre-existing symptoms and healthcare utilization prior to diagnosis of neuroendocrine tumors: a seer-medicare database study. Sci Rep. 2018;8:16863. https:\/\/doi.org\/10.11038\/s41598-16018-35340-16864.","journal-title":"Sci Rep."},{"key":"10021_CR5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1634\/theoncologist.2017-0149","volume":"22","author":"C Shen","year":"2017","unstructured":"Shen C, Chu Y, Halperin DM, et al. Carcinoid syndrome and costs of care during the first year after diagnosis of neuroendocrine tumors among elderly patients. Oncologist. 2017;22:1451\u201362. https:\/\/doi.org\/10.1634\/theoncologist.2017-0149.","journal-title":"Oncologist."},{"key":"10021_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000493319","volume":"108","author":"J Capdevila","year":"2019","unstructured":"Capdevila J, Bodei L, Davies P, et al. Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasms. Neuroendocrinology. 2019;108:18\u201325.","journal-title":"Neuroendocrinology."},{"key":"10021_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.cpet.2014.03.008","volume":"9","author":"V Ambrosini","year":"2014","unstructured":"Ambrosini V, Nanni C, Fanti S. The use of gallium-68 labeled somatostatin receptors in PET\/CT imaging. PET Clin. 2014;9:323\u20139.","journal-title":"PET Clin."},{"key":"10021_CR8","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1530\/ERC-1517-0269","volume":"25","author":"V Marotta","year":"2018","unstructured":"Marotta V, Zatelli MC, Sciammarella C, et al. Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame. Endocr Relat Cancer. 2018;25:R11\u201329. https:\/\/doi.org\/10.1530\/ERC-1517-0269.","journal-title":"Endocr Relat Cancer."},{"key":"10021_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41574-41018-40082-41575","volume":"14","author":"J Hofland","year":"2018","unstructured":"Hofland J, Zandee WT, de Herder WW. Role of biomarker tests for diagnosis of neuroendocrine tumours. Nat Rev Endocrinol. 2018;14:656\u201369. https:\/\/doi.org\/10.1038\/s41574-41018-40082-41575.","journal-title":"Nat Rev Endocrinol."},{"key":"10021_CR10","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/cancers11081113","volume":"11","author":"A Sansone","year":"2019","unstructured":"Sansone A, Lauretta R, Vottari S, et al. Specific and non-specific biomarkers in neuroendocrine gastroenteropancreatic tumors. Cancers (Basel). 2019;11:1113. https:\/\/doi.org\/10.3390\/cancers11081113.","journal-title":"Cancers (Basel)."},{"key":"10021_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.hpb.2018.1009.1016","volume":"21","author":"A Pulvirenti","year":"2019","unstructured":"Pulvirenti A, Rao D, McIntyre CA, et al. Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors. HPB (Oxford). 2019;21:612\u20138. https:\/\/doi.org\/10.1016\/j.hpb.2018.1009.1016 (Epub 2018 Oct 1023).","journal-title":"HPB (Oxford)."},{"key":"10021_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.surg.2019.04.003","volume":"166","author":"S Partelli","year":"2019","unstructured":"Partelli S, Mazza M, Andreasi V, et al. Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life. Surgery. 2019;166:157\u201363.","journal-title":"Surgery."},{"key":"10021_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000488394","volume":"107","author":"DL Chan","year":"2018","unstructured":"Chan DL, Moody L, Segelov E, et al. Follow-up for resected gastroenteropancreatic neuroendocrine tumours: a practice survey of the commonwealth neuroendocrine tumour collaboration (commnets) and the north american neuroendocrine tumor society (NANETS). Neuroendocrinology. 2018;107:32\u201341.","journal-title":"Neuroendocrinology."},{"key":"10021_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1530\/EC-1516-0043","volume":"5","author":"K Oberg","year":"2016","unstructured":"Oberg K, Krenning E, Sundin A, et al. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocr Connect. 2016;5:174\u201387. https:\/\/doi.org\/10.1530\/EC-1516-0043.","journal-title":"Endocr Connect."},{"key":"10021_CR15","first-page":"020","volume":"6","author":"S Partelli","year":"2020","unstructured":"Partelli S, Andreasi V, Muffatti F, Schiavo Lena M, Falconi M. Circulating neuroendocrine gene transcripts (NETest): a postoperative strategy for early identification of the efficacy of radical surgery for pancreatic neuroendocrine tumors. Ann Surg Oncol. 2020;6:020\u201308425.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"10021_CR16","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S1470-2045(15)00186-2","volume":"16","author":"K Oberg","year":"2015","unstructured":"Oberg K, Modlin I, DeHerder W, et al. Consensus on biomarkers for neuroendocrine tumour disease. Lancet Oncol. 2015;16(9):e435\u2013e446. https:\/\/doi.org\/10.1016\/S1470-2045(15)00186-2","journal-title":"Lancet Oncol."},{"issue":"2","key":"10021_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s12020-020-02289-2","volume":"69","author":"FM Laskaratos","year":"2020","unstructured":"Laskaratos FM, Liu M, Malczewska A, et al. Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection. Endocrine. 2020;69(2):430\u201340.","journal-title":"Endocrine."},{"key":"10021_CR18","doi-asserted-by":"crossref","unstructured":"Genc C, Jilesen AP, Nieveen van Dijkum E, et al. Measurement of circulating transcript levels (netest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumours. J Surg Oncol. 2018;118: 37-48.","DOI":"10.1002\/jso.25129"},{"key":"10021_CR19","doi-asserted-by":"publisher","unstructured":"van Treijen MJC, van der Zee D, Heeres BC, et al. Blood Molecular Genomic analysis predicts the disease course of GEP NET patients: a validation study of the predictive value of the NETest\u00ae. Neuroendocrinology. 2020. https:\/\/doi.org\/10.1159\/000509091","DOI":"10.1159\/000509091"},{"issue":"6","key":"10021_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/ejcts\/ezaa018","volume":"57","author":"PL Filosso","year":"2020","unstructured":"Filosso PL, Oberg K, Malczewska A, et al. Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy. Eur J Cardiothorac Surg. 2020;57(6):1195\u2013202.","journal-title":"Eur J Cardiothorac Surg."},{"key":"10021_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fendo.2018.00740.eCollection02018","volume":"9","author":"MJC van Treijen","year":"2018","unstructured":"van Treijen MJC, Korse CM, van Leeuwaarde RS, et al. Blood transcript profiling for the detection of neuroendocrine tumors: results of a large independent validation study. Front Endocrinol (Lausanne). 2018;9:740. https:\/\/doi.org\/10.3389\/fendo.2018.00740.eCollection02018.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10021_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.annonc.2019.1011.1003","volume":"31","author":"K Oberg","year":"2020","unstructured":"Oberg K, Califano A, Strosberg JR, et al. A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood. Ann Oncol. 2020;31:202\u201312. https:\/\/doi.org\/10.1016\/j.annonc.2019.1011.1003.","journal-title":"Ann Oncol."},{"key":"10021_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000446025","volume":"104","author":"M Pavel","year":"2017","unstructured":"Pavel M, Jann H, Prasad V, Drozdov I, Modlin IM, Kidd M. NET blood transcript analysis defines the crossing of the clinical rubicon: when stable disease becomes progressive. Neuroendocrinology. 2017;104:170\u201382.","journal-title":"Neuroendocrinology."},{"key":"10021_CR24","doi-asserted-by":"publisher","unstructured":"Shah MH, Kulke MH, Goldner WS, et al. NCCN Guidelines: neuroendocrine and adrenal tumors, version 3.2018 - Sept 11. J Natl Compr Canc Netw. 2018:693\u2013702. https:\/\/doi.org\/10.6004\/jnccn.2018.0056.","DOI":"10.6004\/jnccn.2018.0056"},{"key":"10021_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000335600","volume":"95","author":"R Salazar","year":"2012","unstructured":"Salazar R, Wiedenmann B, Rindi G, Ruszniewski P. ENETS 2011 consensus guidelines for the management of patients with digestive neuroendocrine tumors: an update. Neuroendocrinology. 2012;95:71\u20133. https:\/\/doi.org\/10.1159\/000335600.","journal-title":"Neuroendocrinology."},{"key":"10021_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/ejcts\/ezx386","volume":"53","author":"P Filosso","year":"2018","unstructured":"Filosso P, Kidd M, Roffinella M, et al. The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumors (BPNET) and as a tool to evaluate surgical resection and disease progression. Eur J Cardiothorac Surg. 2018;53:631\u20139.","journal-title":"Eur J Cardiothorac Surg."},{"key":"10021_CR27","doi-asserted-by":"publisher","first-page":"e0218592","DOI":"10.1371\/journal.pone.0218592","volume":"14","author":"M Kidd","year":"2019","unstructured":"Kidd M, Drozdov IA, Matar S, et al. Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis. PLoS One. 2019;14:e0218592.","journal-title":"PLoS One."},{"key":"10021_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/icvts\/ivu109","volume":"19","author":"G Maurizi","year":"2014","unstructured":"Maurizi G, Ibrahim M, Andreetti C, et al. Long-term results after resection of bronchial carcinoid tumour: evaluation of survival and prognostic factors. Interact Cardiovasc Thorac Surg. 2014;19:239\u201344.","journal-title":"Interact Cardiovasc Thorac Surg."},{"key":"10021_CR29","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.surg.2018.08.015","volume":"165","author":"XF Zhang","year":"2019","unstructured":"Zhang XF, Wu Z, Cloyd J, et al. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group. Surgery. 2019;165:548\u201356.","journal-title":"Surgery."},{"issue":"10","key":"10021_CR30","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/jcm8101630","volume":"8","author":"A Lamarca","year":"2019","unstructured":"Lamarca A, Clouston H, Barriuso J, et al. Follow-up recommendations after curative resection of well-differentiated neuroendocrine tumours: review of current evidence and clinical practice. J Clin Med. 2019;8(10):1630.","journal-title":"J Clin Med."},{"key":"10021_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.1003.1304","volume":"31","author":"M Pavel","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:844\u201360. https:\/\/doi.org\/10.1016\/j.annonc.2020.1003.1304.","journal-title":"Ann Oncol."},{"key":"10021_CR32","doi-asserted-by":"crossref","unstructured":"Grobmyer SR, Vogel SB, McGuigan JE, Copeland EM, Hochwald SN. Reoperative surgery in sporadic Zollinger-Ellison Syndrome: longterm results. J Am Coll Surg. 2009;208: 718-722; discussion 722-714.","DOI":"10.1016\/j.jamcollsurg.2008.11.017"},{"key":"10021_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1210\/jc.2018-01804","volume":"104","author":"A Malczewska","year":"2019","unstructured":"Malczewska A, Bodei L, Kidd M, Modlin IM. Blood mRNA measurement (NETest) for neuroendocrine tumor diagnosis of image-negative liver metastatic disease. J Clin Endocrinol Metab. 2019;104:867\u201372. https:\/\/doi.org\/10.1210\/jc.2018-01804.","journal-title":"J Clin Endocrinol Metab."},{"key":"10021_CR34","doi-asserted-by":"publisher","unstructured":"Malczewska A, Witkowska M, Wojcik-Giertuga M, et al. Prospective Evaluation of the NETest as a liquid biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumours: An ENETS Centre of Excellence Experience. Neuroendocrinology. 2021;111(4):304\u201319. https:\/\/doi.org\/10.1159\/000508106.","DOI":"10.1159\/000508106"},{"key":"10021_CR35","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1038\/ncomms8686","volume":"6","author":"M Sausen","year":"2015","unstructured":"Sausen M, Phallen J, Adleff V, et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun. 2015;6:7686.","journal-title":"Nat Commun."},{"key":"10021_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcmgh.2014.12.008","volume":"1","author":"M Kidd","year":"2015","unstructured":"Kidd M, Modlin I, Bodei L, Drozdov I. Decoding the molecular and mutational ambiguities of gastroenteropancreatic neuroendocrine neoplasm pathobiology. Cell Mol Gastroenterol Hepatol. 2015;1:131\u201353.","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"10021_CR37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.1002.1013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.1002.1013.","journal-title":"Cell."},{"key":"10021_CR38","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1634\/theoncologist.2017-0623","volume":"24","author":"E Liu","year":"2019","unstructured":"Liu E, Paulson S, Gulati A, et al. Assessment of NETest Clinical utility in a US Registry-based study. The Oncologist. 2019;24:783\u201390.","journal-title":"The Oncologist."},{"key":"10021_CR39","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.surg.2015.1006.1056","volume":"159","author":"IM Modlin","year":"2016","unstructured":"Modlin IM, Frilling A, Salem RR, et al. Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies. Surgery. 2016;159:336\u201347. https:\/\/doi.org\/10.1016\/j.surg.2015.1006.1056.","journal-title":"Surgery."},{"key":"10021_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11154-018-9469-9","volume":"19","author":"PE Goretzki","year":"2018","unstructured":"Goretzki PE, Mogl MT, Akca A, Pratschke J. Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract. Rev Endocr Metab Disord. 2018;19:169\u201378.","journal-title":"Rev Endocr Metab Disord."},{"key":"10021_CR41","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/S1470-2045(20)30323-5","volume":"21","author":"L Bodei","year":"2020","unstructured":"Bodei L, Sch\u00f6der H, Baum RP, et al. Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy. Lancet Oncol. 2020;21:e431\u201343.","journal-title":"Lancet Oncol."},{"key":"10021_CR42","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00259-018-3967-6","volume":"45","author":"L Bodei","year":"2018","unstructured":"Bodei L, Kidd MS, Singh A, et al. PRRT Genomic Signature in Blood for Prediction of 177Lu-octreotate Efficacy. Eur J Nucl Med Mol Imaging. 2018;45:1155\u201369.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10021_CR43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ecl.2018.1005.1002","volume":"47","author":"IM Modlin","year":"2018","unstructured":"Modlin IM, Kidd M, Malczewska A, et al. The NETest: the clinical utility of multigene blood analysis in the diagnosis and management of neuroendocrine tumors. Endocrinol Metab Clin North Am. 2018;47:485\u2013504. https:\/\/doi.org\/10.1016\/j.ecl.2018.1005.1002.","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10021_CR44","doi-asserted-by":"publisher","unstructured":"Kidd M, Kitz A, Drozdov I, Modlin I. Neuroendocrine tumor omic gene cluster analysis amplifies the prognostic accuracy of the NETest. Neuroendocrinology. 2020. https:\/\/doi.org\/10.1159\/000508573.","DOI":"10.1159\/000508573"},{"key":"10021_CR45","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.3748\/wjg.v2319.i2315.2348","volume":"19","author":"J Strosberg","year":"2013","unstructured":"Strosberg J, Casciano R, Stern L, et al. United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment. World J Gastroenterol. 2013;19:2348\u201354. https:\/\/doi.org\/10.3748\/wjg.v2319.i2315.2348.","journal-title":"World J Gastroenterol."},{"issue":"4","key":"10021_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1530\/EC-14-0100","volume":"3","author":"IM Modlin","year":"2014","unstructured":"Modlin IM, Aslanian H, Bodei L, Drozdov I, Kidd M. A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by PPIs. Endocr Connect. 2014;3(4):215\u201323.","journal-title":"Endocr Connect."},{"key":"10021_CR47","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1245\/s10434-020-08464-z","volume":"27","author":"S Partelli","year":"2020","unstructured":"Partelli S, Falconi M. ASO Author Reflections: Circulating Neuroendocrine Gene Transcripts (NETest): A Promising Biomarker for Pancreatic Neuroendocrine Tumours (PanNET). Ann Surg Oncol. 2020;27:3937\u20138.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10021-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T16:23:34Z","timestamp":1634315014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10021-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10021"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10021-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Irvin M. Modlin and Ignat A. Drozdov are consultants for Wren Laboratories. Mark Kidd and Alexandra Kitz are employees of Wren Laboratories. Kjell Oberg is a consultant and has an advisory role for Advanced Accelerator Applications. Massimo Falconi has received research grants and has an advisory role for Johnson & Johnson, Novartis, Ipsen, AAA, Mylan, and Celgen. Lisa Bodei is a consultant and has an advisory role for AAA and Ipsen. Pier Luigi Filosso, Andrea Frilling, Anna Malczewska, Ronald Salem, Christos Toumpanakis, Faidon-Marios Laskaratos, Stefano Partelli, Matteo Roffinella, Claudia von Arx, and Beata Kos Kudla have no disclosures to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DISCLOSURES"}}]}}